GI Dynamics has secured about $34.76 million in financing and hopes to raise up to $17.75 million more. The company aims to use the money to finance a U.S. pivotal clinical study of its EndoBarrier Therapy as well as carry out its commercial strategy for the device worldwide, a spokesman for GI Dynamics said.

Full Story:

Related Summaries